Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 58.61
(-4.17%)
INR 58.61
(-4.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 141.4 Million INR | 125.37% |
| 2022 | 62.74 Million INR | -25.96% |
| 2021 | 84.74 Million INR | 327.2% |
| 2020 | 19.83 Million INR | -76.26% |
| 2019 | 83.55 Million INR | 47.73% |
| 2018 | 56.55 Million INR | 4.88% |
| 2017 | 53.92 Million INR | 23.59% |
| 2016 | 43.63 Million INR | -0.75% |
| 2015 | 43.96 Million INR | -72.75% |
| 2014 | 161.33 Million INR | 8.47% |
| 2013 | 148.73 Million INR | 10.72% |
| 2012 | 134.33 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 7.74 Million INR | -68.34% |
| 2023 FY | 141.4 Million INR | 125.37% |
| 2023 Q4 | 36.92 Million INR | 46.35% |
| 2023 Q3 | 25.23 Million INR | 86.7% |
| 2023 Q2 | 13.51 Million INR | 74.42% |
| 2022 Q3 | 26.59 Million INR | 352.57% |
| 2022 Q1 | 1.1 Million INR | -96.23% |
| 2022 Q4 | 24.47 Million INR | -7.96% |
| 2022 Q2 | 5.87 Million INR | 434.18% |
| 2022 FY | 62.74 Million INR | -25.96% |
| 2021 Q3 | 26.06 Million INR | -17.21% |
| 2021 Q1 | -12.44 Million INR | -125.91% |
| 2021 FY | 84.74 Million INR | 327.2% |
| 2021 Q4 | 29.15 Million INR | 11.84% |
| 2021 Q2 | 31.48 Million INR | 352.98% |
| 2020 Q3 | 46.06 Million INR | 55.6% |
| 2020 FY | 19.83 Million INR | -76.26% |
| 2020 Q2 | 29.6 Million INR | -47.13% |
| 2020 Q4 | 48.03 Million INR | 4.28% |
| 2020 Q1 | 55.98 Million INR | -11.95% |
| 2019 Q2 | 42.25 Million INR | -5.82% |
| 2019 FY | 83.55 Million INR | 47.73% |
| 2019 Q1 | 44.86 Million INR | -18.42% |
| 2019 Q3 | 74.55 Million INR | 76.43% |
| 2019 Q4 | 63.58 Million INR | -14.71% |
| 2018 Q4 | 54.99 Million INR | 12.53% |
| 2018 FY | 56.55 Million INR | 4.88% |
| 2018 Q3 | 48.87 Million INR | 18.29% |
| 2018 Q2 | 41.31 Million INR | -29.8% |
| 2018 Q1 | 58.84 Million INR | 22.22% |
| 2017 Q1 | 34.23 Million INR | -10.94% |
| 2017 Q3 | 51.66 Million INR | 96.59% |
| 2017 Q4 | 48.14 Million INR | -6.8% |
| 2017 Q2 | 26.27 Million INR | -23.24% |
| 2017 FY | 53.92 Million INR | 23.59% |
| 2016 FY | 43.63 Million INR | -0.75% |
| 2016 Q3 | 53.38 Million INR | 76.38% |
| 2016 Q4 | 38.43 Million INR | -28.0% |
| 2016 Q2 | 30.26 Million INR | -34.14% |
| 2016 Q1 | 45.95 Million INR | 12.83% |
| 2015 Q4 | 40.73 Million INR | 14.88% |
| 2015 FY | 43.96 Million INR | -72.75% |
| 2015 Q1 | 50.84 Million INR | 33.36% |
| 2015 Q2 | 32.11 Million INR | -36.84% |
| 2015 Q3 | 35.45 Million INR | 10.4% |
| 2014 Q1 | 47.32 Million INR | 22.39% |
| 2014 FY | 161.33 Million INR | 8.47% |
| 2014 Q4 | 38.12 Million INR | -8.93% |
| 2014 Q3 | 41.86 Million INR | 34.14% |
| 2014 Q2 | 31.21 Million INR | -34.05% |
| 2013 Q1 | 69.52 Million INR | 90.75% |
| 2013 FY | 148.73 Million INR | 10.72% |
| 2013 Q3 | 37.69 Million INR | 36.6% |
| 2013 Q2 | 27.59 Million INR | -60.31% |
| 2013 Q4 | 38.66 Million INR | 2.57% |
| 2012 Q2 | 32.84 Million INR | -11.82% |
| 2012 Q4 | 36.44 Million INR | 14.6% |
| 2012 FY | 134.33 Million INR | 0.0% |
| 2012 Q1 | 37.25 Million INR | 24.84% |
| 2012 Q3 | 31.8 Million INR | -3.18% |
| 2011 Q3 | 40.47 Million INR | 0.0% |
| 2011 Q4 | 29.84 Million INR | -26.26% |
| 2010 Q1 | 23.37 Million INR | 0.0% |
| 2009 Q1 | 26.29 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ANG Lifesciences India Limited | 232.73 Million INR | 39.24% |
| Bacil Pharma Limited | -19.95 Thousand INR | 708917.043% |
| BDH Industries Limited | 175.55 Million INR | 19.45% |
| Beryl Drugs Limited | 108.5 Million INR | -30.327% |
| Cian Healthcare Limited | 113.16 Million INR | -24.955% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -669.28% |
| Deccan Health Care Limited | 221.57 Million INR | 36.179% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 57.322% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 36.898% |
| Concord Drugs Limited | 116.7 Million INR | -21.169% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 88.971% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | -4403.124% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | -263.137% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 87.241% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | -26.525% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 90.159% |
| Makers Laboratories Limited | 308.54 Million INR | 54.169% |
| Medi-Caps Limited | 68.09 Million INR | -107.673% |
| MedPlus Health Services Limited | 12.33 Billion INR | 98.853% |
| Panchsheel Organics Limited | 356.44 Million INR | 60.328% |
| Parmax Pharma Limited | 99.31 Million INR | -42.381% |
| Parnax Lab Limited | 552.1 Million INR | 74.387% |
| Patidar Buildcon Limited | -26 Thousand INR | 543980.769% |
| Phaarmasia Limited | 38.89 Million INR | -263.613% |
| PRAVEG LIMITED | 266.99 Million INR | 47.037% |
| Sunil Healthcare Limited | 247.86 Million INR | 42.949% |
| Syschem (India) Limited | 569.04 Million INR | 75.15% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 32.301% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 88.211% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 34929.803% |
| Smruthi Organics Limited | 324.76 Million INR | 56.458% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | -114.217% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 60.912% |
| Trident Lifeline Limited | 119.08 Million INR | -18.749% |
| Transchem Limited | -8.96 Million INR | 1677.169% |
| Trinity League India Limited | 1.23 Million INR | -11378.003% |
| Tyche Industries Limited | 290.84 Million INR | 51.38% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 68.132% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -1311.267% |
| Vivanza Biosciences Limited | 19.38 Million INR | -629.401% |
| Zenith Healthcare Limited | 46.17 Million INR | -206.252% |
| Zenlabs Ethica Limited | 147.75 Million INR | 4.294% |
| Mercury Laboratories Limited | 279.39 Million INR | 49.387% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | -27.429% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 31.911% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 196.409% |
| Roopa Industries Limited | 72.95 Million INR | -93.836% |
| PANJON LTD. | 33.77 Million INR | -318.63% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 294.195% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 893.987% |
| Anuh Pharma Limited | 1.6 Billion INR | 91.181% |
| Crestchem Limited | 51.53 Million INR | -174.38% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 2002.449% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 59.26% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 80.488% |
| Trimurthi Limited | 1.95 Million INR | -7148.027% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 52.924% |
| Norris Medicines Limited | 29.36 Million INR | -381.6% |
| Veerhealth Care Limited | 49.57 Million INR | -185.248% |
| Lactose (India) Limited | 230.3 Million INR | 38.6% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 241.704% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 80.295% |
| Gennex Laboratories Limited | 276.99 Million INR | 48.949% |
| Denis Chem Lab Limited | 596.24 Million INR | 76.283% |
| Colinz Laboratories Limited | 16.35 Million INR | -764.622% |
| Godavari Drugs Limited | 359.01 Million INR | 60.611% |
| Zenotech Laboratories Limited | 337.19 Million INR | 58.064% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 79.025% |
| Bharat Parenterals Limited | 989.46 Million INR | 85.709% |
| Coral Laboratories Limited | 332.39 Million INR | 57.457% |
| Evoq Remedies Limited | 47.43 Million INR | -198.117% |
| Kerala Ayurveda Limited | 447.69 Million INR | 68.414% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 447.323% |
| Natural Capsules Limited | 557.1 Million INR | 74.617% |
| Auro Laboratories Limited | 249.39 Million INR | 43.298% |